Introduction
Hemoglobin Constant Spring (HbCS),' an abnormal hemoglobin with a frequency of up to 5% of some populations in Southeast Asia, has a-chains that are 172 amino acids long, instead of the normal 141 (1, 2) . The elongated a-chain is thought to result from a single base substitution in the chain termination codon of the a2-gene, which results in its translation as an amino acid and allows read-through of the normally untranslated 3' flanking region of the a-globin messenger RNA (mRNA) until the next in-phase termination codon is reached. Heterozygotes for HbCS have -1% of the variant in their red cells, instead of the 20-25% usually found in heterozygotes for a-chain hemoglobin variants. This has been shown to be due to instability of the aCs-mRNA, presumably because of its unusual pattern of translation, rather than to instability ofthe protein (3) . The net effect of the reduced synthesis of aCs-chains is that the acs-gene acts as a form of a-thalassemia, and when it is inherited together with a'-thalassemia (--/acsa) it produces the clinical phenotype of HbH disease (4) .
When compared with other common forms of a-thalassemia in Southeast Asia, most of which are due to gene deletions, the HbCS forms show several unexplained differences. Both heterozygotes (aa/a a) and homozygotes (a/aaCSa) have been reported to show a/fl globin chain synthesis ratios > 1, rather than the expected deficit of a-chain production (5, 6) . Furthermore, since the ccs-gene is associated with a very low output of a-globin chains, homozygotes should have the same clinical 1. Abbreviations used in this paper: Hb, hemoglobin; HbA and HbA2, normal adult hemoglobins; HbF, fetal hemoglobin; HbCS, hemoglobin phenotype as individuals homozygous for the deletion form of a'-thalassemia (-a/-a) or heterozygous for a'-thalassemia (aa/ --). These individuals are mildly anemic, with microcytic, hypochromic red cells, but show no other clinical abnormalities or changes in their Hb pattern (7) . HbCS homozygotes, in contrast, have a moderate hemolytic anemia with splenomegaly, relatively normal red cell indices, and elevated levels of Hb Barts (y4) (6, 8, 9) . Furthermore, patients with HbH disease with only one a-gene (-a/--) are less anemic and have less HbH than those who are heterozygous for both ao-thalassemia and the HbCS mutation (acs/--) (10, 1 1) .
In an attempt to clarify some ofthe unexplained phenotypic differences between HbCS and the deletion forms of a-thalassemia, we have carried out extensive clinical, hematological, and biochemical studies on a patient homozygous for HbCS.
Methods
Patients. P.P., a 32-yr-old Thai male, homozygous for HbCS, gave informed consent for these studies, which were carried out over a 2-wk period in Oxford. Apart from recurrent jaundice as a child, he has had no symptoms. Mild icterus and hepatosplenomegaly (4 and 3 cm, respectively) were the only abnormal physical findings; bone x-rays of chest and skull were normal.
For comparison, studies were also carried out on several patients with various forms of a-thalassemia that were shown by restriction enzyme mapping to be due to gene deletions. The two patients with HbH disease were of Filipino and Chinese origin; they had the typical features of this condition, with HbH levels of II and 8%, respectively, and reticulocyte counts of 7 and 5%. Two patients of Sudanese and Nigerian origins, homozygous for a'-thalassemia (a-/a-), also had typical hematological findings but were clinically unaffected, as was the aRthalassemia heterozygote (aa/--) (previously reported as III in family L of reference 12).
Hematologic studies and hemoglobin analysis. Hematologic studies on blood and bone marrow were performed by standard procedures. Methods for hemoglobin analysis by starch gel electrophoresis, quantitative analysis on cellulose acetate, and measurement offetal Hb (HbF) by alkaline denaturation have been described previously (13) .
For electron microscopy, aspirated bone marrow was taken into heparinized Hanks' solution, fixed in glutaraldehyde (2.5% in 0.1 M phosphate buffer, pH 7.3), and processed for transmission electron microscopy (14) . At least 600 consecutive erythroid cell profiles were assessed for the presence of precipitated globin chains.
Red cell fractionation. Age stratification of red cells was achieved by centrifugation of a column of 14 ml packed red cells at 200,000 g for 60 min at 4°C.
Bone marrow erythroid cells were fractionated according to their degree of maturity on bovine serum albumin gradients (15) .
Ferrokinetic studies. Ferrokinetic studies were carried out after intravenous injection of 9 ml ofthe patient's plasma that had been labeled with 6 MCi 59Fe ferric citrate (specific activity 10 ,Ci/,ug iron; Radiochemical Centre, Amersham Corp., Amersham, England). Subsequent determination of plasma and erythroid iron turnover was as described (16) . Plasma iron and total iron binding capacity were determined by standard methods (17, 18).
Red cell survival studies were carried out using the patient's cells labeled with 5'Cr by the sodium chromate/acid-citrate-dextrose method. Subsequent peripheral red cell 5'Cr counts were corrected for elution (19). Surface 59Fe and 5'Cr counts over heart, sacrum, liver, and spleen
were measured with a collimated sodium iodide scintillation probe. The injection of 5'Cr-labeled red cells was delayed until 30 min after that of 59Fe-labeled plasma to allow determination at each site of the proportion of 59Fe which would cross-count with 5'Cr. All later 5'Cr counts were then corrected for 59Fe cross-counts and analyzed for any excess accumulation of 51Cr in liver and spleen (20 (24) .
Pooled fractions were converted to globin for chain separation as described above.
Separation of globin chains from all the above samples was carried out by carboxymethyl-cellulose chromatography (21, 25) in 8 M urea-2-mercaptoethanol, using a gradient of 0.005-0.033 M Na2HPO4, pH 6.8. Specific activities of the peak tubes were measured after dialysis against 0.5% formic acid and expressed as counts per minute per milligram, using appropriate extinction coefficients (21) .
Results

Hematologic studies
At the time of study the hematologic findings in P.P. were as follows: white blood cells, 9 .0 X 109/liter; erythrocytes, 4 The osmotic fragility curve on fresh blood was within the normal range (50% lysis at 0.435% NaCl, control 0.45%) with no evidence of subpopulations more or less sensitive to lysis. However, after 24 h of storage the red cells showed a markedly increased resistance (50% lysis at 0.26% NaCl vs 0.545% in the control). Autohemolysis showed 1.40 and 3.35% lysis after 48 h with and without glucose, respectively. The whole-blood oxygen dissociation curve was shifted left slightly, with an oxygen pressure at 50% Hb saturation of 24.5 mmHg (control 29.0 mmHg) and a 2-3-diphosphoglycerate level of 6 .55 mmol/liter.
Red cell enzyme measurements showed normal levels of glucose-6-phosphate dehydrogenase, 6-phosphogluconate, adenosine deaminase, glucosephosphate isomerase, phosphofructokinase, lactic acid dehydrogenase, glyceraldehyde phosphate dehydrogenase, and aldolase, with increased levels of pyruvate kinase, hexokinase, glutathione peroxidase, and erythrocyte glutathione reductase, consistent with the high reticulocyte count. Paranitrophenol and pyridine 5'-nucleotide levels were also slightly increased.
A bone marrow aspirate showed hypercellularity that was mainly due to erythroid cells (myeloid/erythroid, 1:3.1) with marked basophilic stippling ofthe late normoblasts. Macrophage iron was moderately increased and siderotic granules were seen in many of the erythroid precursors. Under the electron microscope, inclusion bodies were observed in the cytoplasm of the erythroblasts (Fig. 1 free lysate from a 10-min peripheral blood incubation was chromatographed through Sephadex G-75, two radioactive peaks eluted behind the Hb peak (Fig. 7) . When carrier Hb was added to each of those peaks and the chains were separated, virtually all of the radioactivity eluted with the fi-globin chains in each case; presumably these peaks corresponded to f-chain dimers and f-chain monomers. The Hb peak from this column had an a/f chain synthesis ratio of 2.32, further evidence that there must be a pool of free f-chains within these cells. When the overall a/fl ratio was calculated from these three peaks, a value of 0.77 was obtained, compared with a ratio of 0.69 when the same sample was subjected to chain separation directly; this indicates that no substantial chain loss had occurred during removal of the membranes and gel filtration.
Bone marrow. A deficit of a-chain synthesis was also demonstrated after incubation of a bone marrow sample (Fig. 6 ).
8 10 In this case, however, synthesis of the aCS-chain accounted for 12% of the total a-chain synthesis at 25 min and its specific in the HbCS activity exceeded that of the aA-chain (Table III) Comparison with other forms of a-thalassemia Time course experiments. Globin chain synthesis was also measured in two patients with HbH disease (-a37/_--), two patients homozygous for a'-thalassemia (-a3_7/-a3_7), and one patient heterozygous for a0-thalassemia (aa/--); these diagnoses were proven by restriction enzyme mapping (27) . The globin synthesis ratios in these cases after various incubation periods are shown in Fig. 8 it was not as marked as in the HbCS homozygote, not even in the two HbH disease cases where the (-chain excess was greatest. When pulse-chase experiments were performed in these samples, there was evidence of (-chain degradation in each case (Table  IV) . However, despite the lower a/(3 ratio and hence the greater proportion of excess (-chains in these cases, the amount of (3-chain degradation was less than in P.P.
Gelfiltration. Lysates from incubated reticulocytes were also subjected to gel filtration to estimate the size of the free (3-chain pool in several of these cases (Fig. 9) . In both the aa/--and -a/-a patients, no clear peak of (-chains could be detected (four separate experiments, three patients) at any time between 5 and 60 min of incubation. In contrast, in the HbH disease patient (-a/--) the majority of the incorporated radioactivity migrated in a peak after the hemoglobin peak and was shown to be free (3-chains. The relative proportions of counts under the hemoglobin and free (-chain peaks did not alter appreciably between 5-, 30-, and 60-min incubations.
It seems clear, therefore, that in HbH disease the newly synthesized (3-chains enter a large (-chain pool and are not incorporated appreciably into HbA, even after a 1-h incubation;
thus the Hb fraction eluted from the gel filtration column has an a/(3 radioactivity ratio >4 (a more precise estimate could not be obtained because of the incomplete separation of the two peaks). In the conditions where two of the four a-genes are functional, no free (3-peak can be detected at any time, and the a/(3 radioactivity ratio in the hemoglobin fraction shows the same deficit of a-chains as does the unprocessed total globin.
In these cases, the excess (3-chains seem to be in the form of tetramers, which contrasts completely with the results obtained in the HbCS homozygote, where, with an overall deficit in achain production similar to the -a/-a and aa/--conditions, the pattern on gel filtration more closely resembled that of the HbH disease, with most of the (-chains in a nontetramer form.
Bone marrow incubation in -al/-a. Bone marrow cells from one patient with the -a/-a genotype gave a/(3 ratios of 0.66 and 0.93 after 5 and 60 min of incubation, respectively. This is higher than the ratio obtained in peripheral blood cells of the same patient (a/(3 = 0.42-0.53 over a 15-60-min time course), possibly reflecting greater proteolytic activity in nucleated cells. When the 5-min marrow incubation was subjected to gel filtration, no pool of free (3-chains was observed and the a/(3 ratio ofthe Hb fraction was 0.65, identical with the ratio obtained from the whole globin sample. Similarly, after the addition of nonradioactive HbH, another aliquot chromatographed on Amberlite IRC 50 produced no radioactive globin chains in the HbH peak eluted at 40C and an a/(3 ratio of 0.66 in the HbA peak eluted at room temperature.
It is not clear how an excess of newly synthesized (-chains can occur in these cells yet not be detected either as (-chain dimers/monomers or as (4- the a2-locus to -1-2% of normal. For this reason, HbCS heterozygotes should be phenotypically similar to a'-thalassemia heterozygotes, and this is the case; i.e., they have mild hematological changes and a slightly elevated level of Hb Barts at birth (7). However, HbCS homozygotes are not phenotypically the same as a4-thalassemia homozygotes. The findings in the HbCS homozygote described here are identical to those previously described (6, 8, 9 After transcription of the acs-gene (whether this is at a normal or subnormal level is not yet known) there is instability of the acsamRNA, which decreases during erythroid maturation and which is virtually absent from reticulocytes (3, 30) . The synthesis of C-chains follows the same pattern, decreasing from bone marrow to reticulocytes (2, 31); but once incorporated into a hemoglobin tetramer, the aCs-chains seem to be quite stable in vivo. As a result of the deficit of aCs-chain synthesis, excess /3-chains accumulate in the red cells and are detectable as a pool of f-chain dimers and monomers. However, this pool seems to turn over rapidly, probably as a result of proteolysis, and is destroyed at a rate greater than that seen in other forms of athalassemia with a comparable or even greater deficit ofa-chain synthesis. The net result of these events is that many of the erythrocytes emerging from the bone marrow are recognized as abnormal by the spleen and are rapidly removed from the circulation, resulting in hemolysis and splenomegaly. It seems that those cells that survive this early cull have a more normal lifespan.
This course of events does not explain why the phenotype of homozygous HbCS differs to such a degree from deletion forms of a-thalassemia with comparable deficits in a-chain production. In many ways the findings in our patient homozygous for HbCS are similar to those in HbH disease, albeit the overall degree of chain imbalance is less in HbCS. The presence of a short-lived red cell population has been described in HbH disease (29) , while the electron-microscopic appearances of the HbCS red cell precursors are closer to those of HbH disease than to the different a-thalassemia carrier states. Similarly, the gel filtration experiments show that, as in HbH disease, HbCS ho- The acs-mutation occurs in the a2-globin gene (28, 30, 32) and, while mRNA quantitation suggests a twofold excess of a2-over alI-mRNA in normal individuals (28, 30, 32) , this difference appears to be compensated for by differential translation, producing equal proportions of a-chain from each gene (33) . There is no evidence from quantitation of other abnormal a-chain variants that the output of a-chains directed by each gene differs significantly, and an individual homozygous for an a2-gene deletion (-a'4 2/-a 42) is hematologically indistinguishable from any other individual with an a-gene deletion condition in which only two genes remain active (unpublished observation). It seems unlikely, therefore, that in HbCS the overall degree of a-chain production is significantly less than that in the deletion conditions in which only two a-genes remain; this suggests that the abnormal pattern of translation of the acs-mRNA may itself be responsible for the other abnormalities in homozygous HbCS cells, although how this might affect the rate of proteolysis is not at all clear. Whatever the mechanism, these studies provide clear evidence for a significant overall deficit of a-chain production in the red cell precursors of an HbCS homozygote and show that there is both precipitation and rapid destruction of excess fchains. These processes probably lead to damage to the red cell membrane, shortened red cell survival, and the marked reticulocytosis and splenomegaly that characterize this particular athalassemia syndrome.
